Free
Clinical Science  |   July 1997
Transmyocardial Laser Revascularization Induces Cerebral Microembolization 
Author Notes
  • (von Knobelsdorff, Tonner, Hanel) Staff Anesthesiologist.
  • (Brauer) Resident in Anesthesiology.
  • (am Esch) Professor of Anesthesiology and Chair, Department of Anesthesiology.
  • (Naegele, Stubbe) Staff Surgeon, Department of Thoracic and Cardiovascular Surgery.
  • Received from the University Hospital Eppendorf, Hamburg, Germany. Submitted for publication December 30, 1996. Accepted for publication March 4, 1997. Presented in part in the annual meetings of the International Anesthesia Research Society, Washington, DC, March 8–12, 1996, and the Society of Neurosurgical Anesthesia and Critical Care, New Orleans, Louisiana, October 18, 1996.
  • Address reprint requests to Dr. von Knobelsdorff: Department of Anesthesiology, University Hospital Eppendorf, D-20246 Hamburg, Germany. Address electronic mail to: tonner@uke.uni-hamburg.de.
Article Information
Clinical Science
Clinical Science   |   July 1997
Transmyocardial Laser Revascularization Induces Cerebral Microembolization 
Anesthesiology 7 1997, Vol.87, 58-62. doi:
Anesthesiology 7 1997, Vol.87, 58-62. doi:
Transmyocardial laser revascularization is an alternative treatment for patients with symptomatic coronary artery disease who are refractory to maximal medical therapy but unsuitable for coronary artery bypass graft. [1,2 ] A carbon dioxide laser is used to create transmyocardial channels to initiate neovascularization and thereby improve myocardial blood supply. Complete perforation of the myocardial wall is assessed by determining laser-induced intraventricular bubble formation using transesophageal echocardiography monitoring. [2 ]
It is unclear whether these bubbles embolize to the cerebral circulation or if they impair cerebral oxygen delivery. Emboli in the middle cerebral artery can be detected by transcranial Doppler sonography (TCD). [3,4 ] In addition, fiberoptic jugular bulb oximetry can assess the ratio of global cerebral oxygen delivery and demand. [5–7 ] The purpose of the study, therefore, was to investigate the effects of laser-induced embolization on cerebral blood flow velocity and jugular bulb oxygen saturation (SjO2).
Materials and Methods 
After receiving approval of the ethics committee and informed patient consent, we enrolled 12 patients (American Society of Anesthesiologists physical status III) who were undergoing transmyocardial laser revascularization. We excluded patients with preexisting neurologic dysfunction. All patients were premedicated with flurazepam (1 mg/kg given orally) on the evening before surgery. 60 min before induction, dehydrobenzperidol (0.07 mg/kg) and fentanyl (1.5 micro gram/kg) were given by subcutaneous injection. Anesthesia was induced with fentanyl (15 micro gram/kg), etomidate (50 micro gram/kg), both administered intravenously, and neuromuscular blockade was conducted using pancuronium (100 micro gram/kg given intravenously). After endotracheal intubation, all patients were ventilated to normocapnia with oxygen in air (fractional inspired oxygen tension, 0.3–0.5), and anesthesia was maintained with fentanyl; midazolam, as clinically required; and continuous infusion of etomidate. The radial artery was cannulated to permit measurement of mean arterial pressure and blood sampling. Total length of the procedure was 60–90 min.
Transesophageal echocardiography was used to monitor the transmyocardial laser pulse (Vingmed 750; Sonotron, Vingmed, Horten Norway). Complete perforation of the myocardium was shown by the detection of laser-induced echogenic contrast. The ejection of laser-induced emboli into the aortic root was demonstrated using the two-dimensional mode.
Cerebral blood flow velocity was monitored through a transtemporal approach to the proximal segment (M1) of the left middle cerebral artery using a bidirectional 2-MHz TCD system (Neuroguard; Medasonics, Fremont, USA). The TCD probe was fixed in a frame to keep the depth and angle of insonation constant over time. The flow velocity profiles are presented in real time on an integrated video monitor after flow direction discrimination and calculation of the Doppler frequency shift. The mean flow velocity (Vmean; measured in centimeters per second) was recorded continuously throughout the procedure.
SjO2(expressed as a percentage) and jugular bulb temperature (expressed as degrees centigrade) were measured using a fiberoptic thermodilution catheter (Opticath F 5.5; Abbott Critical Care Systems, Abbott Park, IL) placed in the left jugular bulb via the left internal jugular vein because the patient was turned to the right lateral decubitus position. Appropriate catheter position was verified radiographically before measurements were taken. The catheter was calibrated in vitro before insertion according to the colorimetric method supplied by the manufacturer. Immediately after insertion, and during the observation period, accurate fiberoptic saturation values were verified by drawing blood samples from the catheter and measuring the oxygen saturation rate using a co-oximeter (Radiometer, model OSM 3, Copenhagen, Denmark). If the catheter- and co-oximeter-derived values differed by more than 5%, the catheter was recalibrated in vivo. The catheter display provided a value for reflected light intensity at 5-s intervals.
In each patient, three to eight periods of laser application with three to seven laser pulses per period were obtained. Before, during, and 4 min after administration of laser pulses, Vmean, SjO2, heart rate (expressed as beats/minute), mean arterial pressure, and jugular bulb temperature were monitored continuously and recorded every minute. Arterial blood gas analyses were performed before and 4 min after laser injection. In each patient, one period was evaluated during stable hemodynamic conditions. Data were not collected when systemic hemodynamic parameters were unstable (mean arterial pressure < 60 mmHg) due to surgical manipulation.
A complete neurologic examination was performed by a neurologist in all patients on the day before and on the first day after operation.
Statistics 
Data are presented as means +/- SD. Physiologic variables at given time intervals were tested for Gaussian distribution using the Kolmogorow-Smirnow test. Analysis of variance for repeated measurements was used to test for significant differences over time. Post hoc data were analyzed using paired t tests with Bonferroni corrections for repeated measurements. Statistical significance was assumed at probability values less than 0.05.
Results 
(Table 1) shows demographic data and the number of laser pulses administered. Figure 1depicts a representative transesophageal echocardiography recording after successful transmyocardial perforation. Intraventricular contrast ("snow") rapidly develops after the pulses representing a high concentration of emboli; this is subsequently ejected through the aortic valve. Between 2 and 4 s after the laser pulse, high-frequency signals (indicating emboli) are detected in the middle cerebral artery for a period of 20–60 s by TCD (Figure 2). This typically lasts 20–60 s.
Table 1. Demographic and Intraoperative Data 
Image not available
Table 1. Demographic and Intraoperative Data 
×
Figure 1. Representative transesophageal echocardiography recording during administration of a transmyocardial laser pulse in the left ventricle. (LV, left ventricle; LA, left atrium; LVOT, left ventricular outflow tract). The laser pulse is applied to the left ventricular myocardial wall. Penetration of the laser pulse through the myocardial wall is clearly delineated within the LV (laser pulse). The laser-induced echogenic contrast is distributed in the LV and ejected through the LVOT (laser-induced echogenic contrast “snow”).
Figure 1. Representative transesophageal echocardiography recording during administration of a transmyocardial laser pulse in the left ventricle. (LV, left ventricle; LA, left atrium; LVOT, left ventricular outflow tract). The laser pulse is applied to the left ventricular myocardial wall. Penetration of the laser pulse through the myocardial wall is clearly delineated within the LV (laser pulse). The laser-induced echogenic contrast is distributed in the LV and ejected through the LVOT (laser-induced echogenic contrast “snow”).
Figure 1. Representative transesophageal echocardiography recording during administration of a transmyocardial laser pulse in the left ventricle. (LV, left ventricle; LA, left atrium; LVOT, left ventricular outflow tract). The laser pulse is applied to the left ventricular myocardial wall. Penetration of the laser pulse through the myocardial wall is clearly delineated within the LV (laser pulse). The laser-induced echogenic contrast is distributed in the LV and ejected through the LVOT (laser-induced echogenic contrast “snow”).
×
Figure 2. Representative before, during, and 30 s and 60 s after administration of transmyocardial laser pulses in the basal cerebral arteries. (Vmca, blood flow velocity in the middle cerebral artery; Vaca, blood flow velocity in the anterior cerebral artery.) Two to four seconds after the administration of laser pulses, high-intensity signals indicating the occurrence of microemboli were detected. The signals typically fade after 20–60 s.
Figure 2. Representative before, during, and 30 s and 60 s after administration of transmyocardial laser pulses in the basal cerebral arteries. (Vmca, blood flow velocity in the middle cerebral artery; Vaca, blood flow velocity in the anterior cerebral artery.) Two to four seconds after the administration of laser pulses, high-intensity signals indicating the occurrence of microemboli were detected. The signals typically fade after 20–60 s.
Figure 2. Representative before, during, and 30 s and 60 s after administration of transmyocardial laser pulses in the basal cerebral arteries. (Vmca, blood flow velocity in the middle cerebral artery; Vaca, blood flow velocity in the anterior cerebral artery.) Two to four seconds after the administration of laser pulses, high-intensity signals indicating the occurrence of microemboli were detected. The signals typically fade after 20–60 s.
×
These observations were made in each patient during each laser pulse period. Heart rate (82 +/- 11 beats/min), mean arterial pressure (80 +/- 8 mmHg), partial pressure of carbon dioxide (37.9 +/- 2.0 mmHg), and jugular bulb temperature (35.7 +/- 0.4 [degree sign] Celsius) did not change in the 4 min after the laser pulse. The Vmean(36 +/- 6 cm/s) and SjO2(56 +/- 8%) also remained unchanged. All patients were awake and oriented on the first postoperative day. No neurologic abnormalities were noted.
Discussion 
Ultrasonic echo monitoring can detect solid or gaseous microemboli. [8,9 ] In dogs, the sensitivity of echocardiography was high, with values for specificity that were reduced by as much as the size of the emboli decreased. [10,11 ] The studies cited show that the snow-like clouds observed in the present study are likely to correspond to embolic material that is transported into the systemic circulation. As with transesophageal echocardiography in the heart, [12 ] TCD can detect intraluminar emboli in cerebral vessels. Russel et al. [13 ] have shown in rabbits that intraarterial injection of particles was invariably followed by the appearance of high-intensity signals on the screen. In vivo Markus and Brown [14 ] found a linear relation between the embolus size and the duration of the high amplitude and a relation between the embolus size and the maximum amplitude of the Doppler signal. The regression lines differed for different embolic materials. However, according to Russel et al., [13 ] identification of the material embolized, judging from the signal characteristics of the Doppler tracing, will barely be possible. Furthermore, TCD is prone to movement artifacts and electromagnetic disturbances, both of which may cause high-intensity signals, thus mimicking embolization episodes. In our study, the sequential appearance of laser pulse, “snow clouds” in transesophageal echocardiography, and acoustic phenomena in TCD after a transit-time of 2–4 s strongly suggest the existence of arterial emboli, ruling out artifacts as a source of the signals.
Van Leeuwen et al. [15,16 ] noted the possibility of the formation of intravascular emboli after the use of laser. In a hemoglobin solution, those authors demonstrated photographically that an excimer laser pulse (using the radiation of an electronically “excited dimer” molecule) formed a fast-expanding (2.3 mm in diameter within 100 micro s) and imploding vapor bubble (within 250 micro s after the laser pulse). The bubble reexpanded and disappeared at 500 micro s, but some small bubbles remained long after the laser pulse. The same group of researchers observed the formation of vapor bubbles in vivo in rabbits during laser angioplasty of the femoral artery. [16 ] In the vicinity of the site of vapor bubble formation, severe arterial wall lesions, including media-necrosis and vascular dissection, were observed and appeared not to be due to the effect of the laser pulse itself. The authors ascribed their observations to the potential formation of vapor bubbles. Absorption of the energy of the laser pulse thus would have lead to vaporization of blood due to energy absorption by hemoglobin and tissue proteins. Freed et al. [17 ] found that during implosion of vapor bubbles, violent peak pressure gradients occur, which along with local damage of blood particles and vessel walls leads to formation of bubbles from gases dissolved in blood (oxygen, nitrogen, and carbon dioxide). In addition, those authors have shown that cavitation after implosion fragmented circulating microbubbles into many gaseous microemboli (measuring < 15 micro meter) that may persist briefly in the circulation. These mechanisms may serve, in part, to explain the observations that we made in our study: The emboli detected are likely to be due to vaporization of blood, particles, and solutes after the impact of the carbon dioxide laser. Thus they probably consist of vapor and gas. Recently researchers have shown that microbubbles in flowing blood are not absorbed very quickly. [18 ] However, Feinstein et al. [19 ] found that only arterial emboli larger than 15 micro meter lead to temporary occlusion of more than 1 min, whereas emboli of less than 10 micro meter in diameter pass the capillary vasculature unrestricted. Thus many small emboli may cause the phenomena observed without leading to clinical neurologic abnormalities.
The laser pulse may cause the formation of cell debris and toxic photoproducts, which both may contribute to the occurrence of emboli. In dogs after Argon-laser-angioplasty, Gal et al. [20 ] found levels of carboxyhemoglobin and hydrogen cyanide that were much less than accepted clinical toxic limits, but microparticulate debris was not detected. Therefore the occurrence of debris and toxic photoproducts due to the incineration of organic material may play only a minor role for cerebral embolization.
Our finding that SjO2remained largely constant over time indicates that the global cerebral oxygen balance is not grossly impaired by embolic events. Jugular bulb oxygen saturation does not detect regional cerebral ischemia based on microembolization. Only occlusion of a major vessel or diffuse occlusion of about 10% of the arterial vascular volume with an increase of oxygen extraction would induce a change in SjO2. In our study, the latter remained unchanged in the observation periods, suggesting that an impairment of cerebral oxygen balance may occur only on a regional basis, undetectable by SjO2.
We detected no major neurologic complications, probably because of the small sample size of 12 patients studied. However, measures should be taken clinically to reduce the risk of cerebral embolization during transmyocardial laser revascularization. Because oxygen bubbles dissolved about ten times faster than nitrogen bubbles, [21 ] use of oxygen (fractional inspired oxygen tension, 1.0) 10 min before the procedure may be beneficial. Use of nitrous oxide appears to be potentially harmful because its high diffusion capacity into preformed bubbles. In addition, systemic hemodynamic variables should be adjusted to an optimum level to prevent cerebral hypoperfusion that may aggravate effects of the emboli on the cerebral circulation.
Our results show that transmyocardial laser revascularization leads to cerebral embolization. The ratio of global cerebral oxygen delivery and oxygen demand remains unchanged if perfusion pressure is maintained within sufficient limits. Based on the assumption that the emboli observed by transesophageal echocardiography and TCD consist of gas, nitrogen and nitrous oxide should be discontinued before the laser pulse is administered. We did not perform neuropsychiatric tests in this study. However, none of the 12 patients exhibited major neurologic deficits on the first day after operation, indicating that transmyocardial laser revascularization did not cause significant cerebral ischemia. Further studies should evaluate the potential influence of the embolic events on postoperative neuropsychiatric performance using more meticulous methods of testing.
References 
References 
Frazier OH, Cooley DA, Kadipasaoglu KA, Pehlivanoglu S, Lindenmeir M, Barasch E, Conger JL, Wilanski S, Moore WH: Myocardial revascularization with laser. Circulation 1995; 92:II-58-II-65.
Deckelbaum LI: Cardiovascular applications of laser technology. Lasers in Surgery and Medicine 1994; 15:315-41.
Padayachee TS, Parsons S, Theobold R, Linley J, Gosling RG, Deverall PB: The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: a transcranial doppler ultrasound investigation using membrane and bubble oxygenators. Ann Thorac Surg 1987; 44:298-302.
Pugsley W: The use of doppler ultrasound in the assessment of microemboli during cardiac surgery. Perfusion 1989; 4:115-22.
Cruz J: On-line monitoring of global cerebral hypoxia in acute brain injury. J Neurosurg 1993; 79:228-33.
Nakajima T, Kuro M, Hayashi Y, Kitaguchi K, Uchida O, Takaki O: Clinical evaluation of cerebral oxygen balance during cardiopulmonary bypass: on-line continuous monitoring of jugular venous oxyhemoglobin saturation. Anesth Analg 1992; 74:630-5.
von Knobelsdorff G, Hanel F, Werner C, Schulte am Esch J: Jugular bulb oxygen saturation and middle cerebral blood flow velocity during cardiopulmonary bypass. J Neurosurg Anesth 1997; 9:128-33.
Teague SM, Sharma MK: Detection of paradoxical cerebral echo contrast embolization by transcranial doppler ultrasound. Stroke 1991; 22:740-5.
Clark RE, Dietz DR, Miller JG: Continuous detection of microemboli during cardiopulmonary bypass in animals and man. Circulation 1976; 54:III-74-8.
Duff HJ, Buda AJ, Kramer R, Strauss HD, David TE, Berman ND: Detection of entrapped intracardiac air with intraoperative echocardiography. Am J Cardiol 1980; 46:255-60.
Furuya H, Suzuki T, Okumura F, Kishi Y, Uefuji T: Detection of air embolism by transesophageal echocardiography. Anesthesiology 1983; 58:124-9.
Oka Y, Inoue T, Hong Y, Sisto DA, Strom JA, Frater RWM: Retained intracardiac air: transesophageal echocardiography for definition of incidence and monitoring removal by improved techniques. J Thorac Cardiovasc Surg 1986; 91:329-38.
Russel D, Madden KP, Clark WM, Sandset PM, Zivin JA: Detection of arterial emboli using doppler ultrasound in rabbits. Stroke 1991; 22:253-8.
Markus HS, Brown MM: Differentiation between different pathological cerebral embolic materials using transcranial doppler in an in vitro model. Stroke 1993; 24:1-5.
van Leeuwen TG, van Erven L, Meertens JH, Motamedi M, Post MJ, Borst C: Origin of arterial wall dissections induced by pulsed excimer and mid-infrared laser ablation in the pig. J Am Coll Cardiol 1992; 19:1610-8.
van Leeuwen TG, Meertens JH, Velema E, Post MJ, Borst C: Intraluminar vapor bubble induced by excimer laser pulse causes microsecond arterial dilation and invagination leading to extensive wall damage in the rabbit. Circulation 1993; 87:1258-63.
Freed D, Walker WF, Dube CM, Tokuno T: Effects of vaporous cavitation near prosthetic surfaces. Trans Am Soc Artif Intern Organs 1981; 27:105-9.
Dexter F, Hindman BJ, Marshall JS: Estimate of the maximum absorption rate of microscopic arterial air emboli after entry into the arterial circulation during cardiac surgery. Perfusion 1996; 11:445-50.
Feinstein SB, Shah PM, Bing RJ, Meerbaum S, Corday E, Chang BL, Santillan G, Fujibayashi Y: Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol 1984; 4:595-600.
Gal D, Fonger JD, Rastegar H, DeJesus ST, Clarke RH, Isner JM: Analysis of photoproducts, free radicals, and particulate debris generated during in vivo argon laser myoplasty. Lasers in Surgery and Medicine 1991; 11:125-32.
Hlastala MP, Van Liew HD: Absorption of in vivo inert gas bubbles. Resp Physiol 1975; 24:147-58.
Figure 1. Representative transesophageal echocardiography recording during administration of a transmyocardial laser pulse in the left ventricle. (LV, left ventricle; LA, left atrium; LVOT, left ventricular outflow tract). The laser pulse is applied to the left ventricular myocardial wall. Penetration of the laser pulse through the myocardial wall is clearly delineated within the LV (laser pulse). The laser-induced echogenic contrast is distributed in the LV and ejected through the LVOT (laser-induced echogenic contrast “snow”).
Figure 1. Representative transesophageal echocardiography recording during administration of a transmyocardial laser pulse in the left ventricle. (LV, left ventricle; LA, left atrium; LVOT, left ventricular outflow tract). The laser pulse is applied to the left ventricular myocardial wall. Penetration of the laser pulse through the myocardial wall is clearly delineated within the LV (laser pulse). The laser-induced echogenic contrast is distributed in the LV and ejected through the LVOT (laser-induced echogenic contrast “snow”).
Figure 1. Representative transesophageal echocardiography recording during administration of a transmyocardial laser pulse in the left ventricle. (LV, left ventricle; LA, left atrium; LVOT, left ventricular outflow tract). The laser pulse is applied to the left ventricular myocardial wall. Penetration of the laser pulse through the myocardial wall is clearly delineated within the LV (laser pulse). The laser-induced echogenic contrast is distributed in the LV and ejected through the LVOT (laser-induced echogenic contrast “snow”).
×
Figure 2. Representative before, during, and 30 s and 60 s after administration of transmyocardial laser pulses in the basal cerebral arteries. (Vmca, blood flow velocity in the middle cerebral artery; Vaca, blood flow velocity in the anterior cerebral artery.) Two to four seconds after the administration of laser pulses, high-intensity signals indicating the occurrence of microemboli were detected. The signals typically fade after 20–60 s.
Figure 2. Representative before, during, and 30 s and 60 s after administration of transmyocardial laser pulses in the basal cerebral arteries. (Vmca, blood flow velocity in the middle cerebral artery; Vaca, blood flow velocity in the anterior cerebral artery.) Two to four seconds after the administration of laser pulses, high-intensity signals indicating the occurrence of microemboli were detected. The signals typically fade after 20–60 s.
Figure 2. Representative before, during, and 30 s and 60 s after administration of transmyocardial laser pulses in the basal cerebral arteries. (Vmca, blood flow velocity in the middle cerebral artery; Vaca, blood flow velocity in the anterior cerebral artery.) Two to four seconds after the administration of laser pulses, high-intensity signals indicating the occurrence of microemboli were detected. The signals typically fade after 20–60 s.
×
Table 1. Demographic and Intraoperative Data 
Image not available
Table 1. Demographic and Intraoperative Data 
×